Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP hydrolysis activity	RAD51D KATNAL2 DDX31 ATRX CFTR DHX38 SMC6 DNAH2 PEX6 ABCC5 SRPRA MCM7 DNAH7 ABCC6 DNAH12 CHD5 ABCB8 MACF1 ABCC12 ABCG8	2.06e-09	441	175	20	GO:0016887
GeneOntologyMolecularFunction	ATP-dependent activity	RAD51D MRE11 KATNAL2 DDX31 ATRX CFTR DHX38 SMC6 DNAH2 PEX6 ABCC5 SRPRA MCM7 DNAH7 ABCC6 DNAH12 CHD5 ABCB8 MACF1 ABCC12 ABCG8	1.07e-07	614	175	21	GO:0140657
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	RAD51D KATNAL2 DDX31 ATRX CFTR DHX38 SMC6 DNAH2 PEX6 ABCC5 SRPRA MCM7 DNAH7 ABCC6 TRIM23 DNAH12 RHOBTB2 CHD5 ABCB8 MACF1 ABCC12 GTPBP3 ABCG8	3.20e-07	775	175	23	GO:0017111
GeneOntologyMolecularFunction	pyrophosphatase activity	RAD51D KATNAL2 DDX31 ATRX CFTR DHX38 SMC6 DNAH2 PEX6 ABCC5 SRPRA MCM7 DNAH7 ABCC6 TRIM23 DNAH12 RHOBTB2 CHD5 ABCB8 MACF1 ABCC12 GTPBP3 ABCG8	1.26e-06	839	175	23	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	RAD51D KATNAL2 DDX31 ATRX CFTR DHX38 SMC6 DNAH2 PEX6 ABCC5 SRPRA MCM7 DNAH7 ABCC6 TRIM23 DNAH12 RHOBTB2 CHD5 ABCB8 MACF1 ABCC12 GTPBP3 ABCG8	1.28e-06	840	175	23	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	RAD51D KATNAL2 DDX31 ATRX CFTR DHX38 SMC6 DNAH2 PEX6 ABCC5 SRPRA MCM7 DNAH7 ABCC6 TRIM23 DNAH12 RHOBTB2 CHD5 ABCB8 MACF1 ABCC12 GTPBP3 ABCG8	1.28e-06	840	175	23	GO:0016818
GeneOntologyMolecularFunction	ABC-type transporter activity	CFTR ABCC5 ABCC6 ABCB8 ABCC12 ABCG8	4.25e-06	49	175	6	GO:0140359
GeneOntologyMolecularFunction	ATPase-coupled inorganic anion transmembrane transporter activity	CFTR ABCC5 ABCC6	7.59e-05	10	175	3	GO:0043225
GeneOntologyMolecularFunction	dihydroorotase activity	CAD DHODH	7.64e-05	2	175	2	GO:0004151
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH2 CCDC88B DNAH7 DNAH12	9.90e-05	28	175	4	GO:0051959
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	CFTR ABCC5 ABCC6 ABCB8 ABCC12 ABCG8	3.99e-04	109	175	6	GO:0042626
GeneOntologyMolecularFunction	6-phosphofructo-2-kinase activity	PFKFB1 PFKFB3	4.53e-04	4	175	2	GO:0003873
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH2 DNAH7 DNAH12	4.90e-04	18	175	3	GO:0008569
GeneOntologyMolecularFunction	fructose-2,6-bisphosphate 2-phosphatase activity	PFKFB1 PFKFB3	7.51e-04	5	175	2	GO:0004331
GeneOntologyMolecularFunction	carbohydrate kinase activity	NAGK PFKFB1 PFKFB3	7.84e-04	21	175	3	GO:0019200
GeneOntologyMolecularFunction	ligase activity, forming carbon-nitrogen bonds	CAD TTLL3 PFAS PPCS	1.19e-03	53	175	4	GO:0016879
GeneOntologyBiologicalProcess	'de novo' pyrimidine nucleobase biosynthetic process	CAD MTOR DHODH	1.18e-05	6	175	3	GO:0006207
GeneOntologyBiologicalProcess	ribonucleoside diphosphate metabolic process	CAD INSR PFKFB1 PFKFB3 MTOR DHODH DLG1 DHTKD1	3.07e-05	143	175	8	GO:0009185
GeneOntologyBiologicalProcess	pyrimidine nucleobase biosynthetic process	CAD MTOR DHODH	3.26e-05	8	175	3	GO:0019856
GeneOntologyBiologicalProcess	nucleoside diphosphate metabolic process	CAD INSR PFKFB1 PFKFB3 MTOR DHODH DLG1 DHTKD1	4.12e-05	149	175	8	GO:0009132
GeneOntologyBiologicalProcess	response to xenobiotic stimulus	DGCR2 AADAC CAD FMO4 HDAC5 CFTR ABCC5 PFAS MCM7 ADCY1 ABCC6 PARP4 BRAF EHMT2 ABCG8	4.35e-05	525	175	15	GO:0009410
GeneOntologyBiologicalProcess	mitotic recombination	RAD51D MRE11 SMC6 TEP1	7.54e-05	27	175	4	GO:0006312
GeneOntologyCellularComponent	inner dynein arm	DNAH2 DNAH7 DNAH12	6.74e-05	10	176	3	GO:0036156
GeneOntologyCellularComponent	nuclear body	MRE11 HDAC5 ATRX AFF3 SMC6 TUT1 NPHP4 PRX BPNT2 SBF1 RNF6 EHMT2 MTOR CHD5 YLPM1 SLTM SAFB2 KAZN NXF1	2.28e-04	903	176	19	GO:0016604
Domain	-	RAD51D KATNAL2 DDX31 ATRX CFTR DHX38 SMC6 DNAH2 PEX6 ABCC5 SRPRA MCM7 PFKFB1 PFKFB3 TEP1 DNAH7 ABCC6 TRIM23 SBNO2 DNAH12 TJP1 RHOBTB2 CHD5 ABCB8 YLPM1 DLG1 ABCC12 GTPBP3 ABCG8 CNP	1.17e-11	746	174	30	3.40.50.300
Domain	P-loop_NTPase	RAD51D KATNAL2 DDX31 ATRX CFTR DHX38 SMC6 DNAH2 PEX6 ABCC5 SRPRA MCM7 PFKFB1 PFKFB3 TEP1 DNAH7 ABCC6 TRIM23 SBNO2 DNAH12 TJP1 RHOBTB2 CHD5 ABCB8 YLPM1 DLG1 ABCC12 GTPBP3 ABCG8 CNP	2.66e-10	848	174	30	IPR027417
Domain	AAA	RAD51D KATNAL2 CFTR DNAH2 PEX6 ABCC5 SRPRA MCM7 DNAH7 ABCC6 DNAH12 ABCB8 ABCC12	9.26e-10	144	174	13	SM00382
Domain	AAA+_ATPase	RAD51D KATNAL2 CFTR DNAH2 PEX6 ABCC5 SRPRA MCM7 DNAH7 ABCC6 DNAH12 ABCB8 ABCC12	9.26e-10	144	174	13	IPR003593
Domain	ABC_transporter_CS	CFTR ABCC5 ABCC6 ABCB8 ABCC12 ABCG8	2.38e-06	42	174	6	IPR017871
Domain	ABC_membrane	CFTR ABCC5 ABCC6 ABCB8 ABCC12	2.44e-06	24	174	5	PF00664
Domain	ABC_tran	CFTR ABCC5 ABCC6 ABCB8 ABCC12 ABCG8	5.32e-06	48	174	6	PF00005
Domain	ABC_TRANSPORTER_2	CFTR ABCC5 ABCC6 ABCB8 ABCC12 ABCG8	5.32e-06	48	174	6	PS50893
Domain	ABC_TM1F	CFTR ABCC5 ABCC6 ABCB8 ABCC12	5.47e-06	28	174	5	PS50929
Domain	ABC1_TM_dom	CFTR ABCC5 ABCC6 ABCB8 ABCC12	5.47e-06	28	174	5	IPR011527
Domain	ABC_TRANSPORTER_1	CFTR ABCC5 ABCC6 ABCB8 ABCC12 ABCG8	6.02e-06	49	174	6	PS00211
Domain	ABC_transporter-like	CFTR ABCC5 ABCC6 ABCB8 ABCC12 ABCG8	6.78e-06	50	174	6	IPR003439
Domain	Dynein_heavy_chain_D4_dom	DNAH2 DNAH7 DNAH12	2.68e-04	14	174	3	IPR024317
Domain	Dynein_heavy_dom-2	DNAH2 DNAH7 DNAH12	2.68e-04	14	174	3	IPR013602
Domain	DHC_N2	DNAH2 DNAH7 DNAH12	2.68e-04	14	174	3	PF08393
Domain	AAA_8	DNAH2 DNAH7 DNAH12	2.68e-04	14	174	3	PF12780
Domain	DHC_fam	DNAH2 DNAH7 DNAH12	3.33e-04	15	174	3	IPR026983
Domain	Dynein_heavy	DNAH2 DNAH7 DNAH12	3.33e-04	15	174	3	PF03028
Domain	Dynein_heavy_dom	DNAH2 DNAH7 DNAH12	3.33e-04	15	174	3	IPR004273
Domain	PDZ	FRMPD4 MPDZ PRX RHPN1 MAST4 TJP1 DLG1	3.58e-04	141	174	7	PF00595
Domain	Znf_FYVE_PHD	SPIRE2 ATRX ING1 KMT2D CHD5 BSN RUFY4	4.60e-04	147	174	7	IPR011011
Domain	PDZ	FRMPD4 MPDZ PRX RHPN1 MAST4 TJP1 DLG1	4.79e-04	148	174	7	SM00228
Domain	6Phosfructo_kin	PFKFB1 PFKFB3	5.11e-04	4	174	2	IPR013079
Domain	6Pfruct_kin	PFKFB1 PFKFB3	5.11e-04	4	174	2	IPR003094
Domain	6PF2K	PFKFB1 PFKFB3	5.11e-04	4	174	2	PF01591
Domain	-	FRMPD4 MPDZ PRX RHPN1 MAST4 TJP1 DLG1	5.20e-04	150	174	7	2.30.42.10
Domain	PDZ	FRMPD4 MPDZ PRX RHPN1 MAST4 TJP1 DLG1	5.41e-04	151	174	7	PS50106
Domain	PDZ	FRMPD4 MPDZ PRX RHPN1 MAST4 TJP1 DLG1	5.62e-04	152	174	7	IPR001478
Pathway	KEGG_ABC_TRANSPORTERS	CFTR ABCC5 ABCC6 ABCB8 ABCC12 ABCG8	3.31e-06	44	133	6	M11911
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA5B2 DGCR2 SPIRE2 ANKS6 TRIO NLRX1 HECTD4 PEX6 PFAS NCLN TEP1 NPHP4 ZBTB42 ADGRA2 BTN3A2 ANO8 SBNO2 MPRIP PPP1R26 RHPN1 KMT2D SCAP CELSR2 SBF1 INF2 MTOR CHD5 CPSF1 PIGW SH3BP5L SPEN PLXNA1	1.51e-15	1105	177	32	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SLAIN2 SPIRE2 TRIO CLASP1 AAK1 MPDZ LARP1B DNAH7 MPRIP MAST4 BRAF SBF1 TJP1 MTOR PLEKHG3 SVIL MEPCE GIGYF2 MACF1 SH3BP5L TSC22D4 TNS3 DYRK2	1.02e-10	861	177	23	36931259
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CAD TRIO CLASP1 HECTD4 AAK1 MPDZ MPRIP FRY CELSR2 SBF1 UBR5 EHMT2 TJP1 MTOR SVIL YLPM1 SAFB2 GIGYF2 DLG1 MACF1 BSN CNP CNTN1	8.92e-10	963	177	23	28671696
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SLAIN2 MRE11 KATNAL2 PRSS8 CAD DDX31 ATRX CLASP1 DHX38 AAK1 MPDZ SRPRA UFL1 NPM3 MPRIP MED4 PAXBP1 SBF1 EHMT2 PLEKHG3 TPP1 DLG1 MACF1 ATF1 SPEN NXF1 CNP	1.15e-08	1497	177	27	31527615
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	SLAIN2 IRF2BP1 NPHP4 KMT2D UBR5 TJP1 SVIL GIGYF2 SPEN PCCB	4.02e-08	184	177	10	32908313
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CAD DDX31 HDAC5 ATRX CLASP1 DHX38 PFAS MCM7 ZCCHC2 MPRIP UBR5 MACF1 SH3BP5L BSN SPEN NXF1	6.55e-08	588	177	16	38580884
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	MRE11 CAD IRF2BP1 INSR MCM7 UFL1 NCLN UBR5 TJP1 PLEKHG3 SVIL YLPM1 SLTM SAFB2 HNRNPA0 CPSF1 GIGYF2 MACF1 SPEN NXF1 CNP	6.88e-08	1024	177	21	24711643
Pubmed	Human transcription factor protein interaction networks.	FLG MRE11 CAD DDX31 HDAC5 IRF2BP1 ATRX ING1 NPM3 ZIC3 MPRIP KMT2D MED4 EHMT2 CHD5 SVIL YLPM1 MRPS9 CPSF1 GIGYF2 ATF1 SPEN PCCB NXF1 FBXW7	7.66e-08	1429	177	25	35140242
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SLAIN2 ANKS6 INSR SMC6 ABCC5 SRPRA MCM7 KBTBD2 PKHD1L1 DNAH7 TRIM23 UBR5 EHMT2 TJP1 MRPS9 DLG1 SPEN PCCB	1.07e-07	777	177	18	35844135
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	MRE11 SMC6 AAK1 SRPRA LARP1B MPRIP PARP4 SBF1 TJP1 YLPM1 GIGYF2 MACF1 SPEN PCCB NXF1 CNP TNS3	2.04e-07	724	177	17	36232890
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ATRX DHX38 PEX6 MPDZ PFAS SRPRA NCLN SBNO2 PARP4 SBF1 TPP1 ANAPC2 SLTM GIGYF2 DLG1 NXF1	2.53e-07	650	177	16	38777146
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	HDAC5 ADGRV1 ADGRA2 SCAP TENM4 UBR5 RHOBTB2 CHD5 GIGYF2 MACF1	2.63e-07	225	177	10	12168954
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MRE11 CAD DDX31 DHX38 PFAS SBF1 UBR5 TJP1 MTOR YLPM1 SLTM CPSF1 GIGYF2 MACF1 SPEN NXF1	2.69e-07	653	177	16	22586326
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DHX38 PFAS ZCCHC2 NPHP4 PRX ANO8 PPP1R26 PARP4 SCAP PLEKHG3 SAFB2 MACF1 KAZN DHTKD1	2.69e-07	493	177	14	15368895
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MRE11 CAD ATRX TRIO DHX38 SMC6 PFAS MCM7 UFL1 NCLN NPM3 PAXBP1 MTOR SLTM SAFB2 MRPS9 HNRNPA0 CPSF1 GIGYF2 PNPLA8 BSN SPEN PLXNA1 NXF1	2.85e-07	1425	177	24	30948266
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	CAD ATRX TRIO ADCY1 CELSR2 EHMT2 MTOR YLPM1 DLG1 MACF1 ATF1 CNTN1	3.47e-07	358	177	12	32460013
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	MRE11 KATNAL2 DDX31 DHX38 NPM3 MPRIP PAXBP1 EHMT2 TJP1 MEPCE SLTM SAFB2 CRNN MRPS9 HNRNPA0 CPSF1 GIGYF2 KAZN	3.78e-07	847	177	18	35850772
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	FLG MRE11 CAD UFL1 CAVIN3 NCLN MPRIP EHMT2 TJP1 MRPS9 HNRNPA0 GIGYF2 MACF1 CNP FBXW7	5.12e-07	601	177	15	33658012
Pubmed	Histiocytic sarcoma: New insights into FNA cytomorphology and molecular characteristics.	SPI1 CD163 KMT2D	5.16e-07	4	177	3	28805986
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TRIO CLASP1 MPDZ PFAS LARP1B MAST4 UBR5 MACF1 TNS3	1.38e-06	209	177	9	36779422
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	CAD MPDZ LARP1B MPRIP TJP1 SVIL MEPCE HNRNPA0 GIGYF2 NXF1	1.58e-06	274	177	10	34244482
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	IRF2BP1 TUT1 UBR5 EHMT2 ANAPC2 MEPCE MRPS9 MACF1 SPEN CNP	2.05e-06	282	177	10	23667531
Pubmed	Functional proteomics mapping of a human signaling pathway.	DGCR2 PRSS8 NAGK IRF2BP1 ATRX PEX6 PPP1R26 KMT2D MED4 MAST4 UBR5 ANAPC2 YLPM1 MACF1	2.29e-06	591	177	14	15231748
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	MRE11 ZBTB17 ATRX ING1 DHX38 SRPRA NCLN NPM3 KMT2D MED4 PAXBP1 EHMT2 ANAPC2 YLPM1 SLTM SAFB2 HNRNPA0 CPSF1 ATF1 SPEN NXF1	3.01e-06	1294	177	21	30804502
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	ATRX CLASP1 MPRIP AJM1 SLC4A10 SAFB2 FGA MACF1 BSN	3.13e-06	231	177	9	16452087
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SLAIN2 DGCR2 HECTD4 AAK1 UFL1 ADGRV1 KBTBD2 ADGRA2 MAST4 SBF1 CHD5 ANAPC2 BSN	3.58e-06	529	177	13	14621295
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	FLG MRE11 ANKS6 HDAC5 PDE8A IRF2BP1 ATRX CLASP1 SMC6 AAK1 CDH23 MCM7 NCLN NPHP4 MPRIP MED4 MTOR CRNN GIGYF2 CNP DYRK2	4.14e-06	1321	177	21	27173435
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	RAD51D MRE11 CAD ATRX DHX38 SMC6 PFAS UFL1 MED4 SCAP UBR5 EHMT2 DHODH YLPM1 SLTM MRPS9 HNRNPA0 CPSF1 GIGYF2 NXF1 FBXW7	4.43e-06	1327	177	21	32694731
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MRE11 CAD IRF2BP1 ATRX DHX38 SMC6 MCM7 UFL1 MED4 UBR5 EHMT2 YLPM1 MEPCE SLTM SAFB2 CPSF1 ATF1 NXF1	4.77e-06	1014	177	18	32416067
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	MRE11 HDAC5 ATRX ING1 MCM7 ZNF831 NPM3 KMT2D PAXBP1 EHMT2 SLTM SPEN	5.71e-06	469	177	12	27634302
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MRE11 CAD DHX38 AAK1 PFAS MCM7 NPM3 MPRIP SBF1 UBR5 INF2 PLEKHG3 TPP1 SLTM SAFB2 HNRNPA0 CPSF1 MACF1 NXF1 CNP TNS3	5.96e-06	1353	177	21	29467282
Pubmed	Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins.	CAD HDAC5 HECTD4 MPRIP BRAF MTOR GIGYF2 SH3BP5L	6.34e-06	190	177	8	15161933
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	MRE11 CAD DHX38 SRPRA MCM7 MPRIP TJP1 PLEKHG3 CHD5 SVIL MEPCE SLTM SAFB2 MRPS9 HNRNPA0 CPSF1 DLG1 SPEN NXF1 CNP	7.03e-06	1257	177	20	36526897
Pubmed	Oligodendrocyte precursor cell-intrinsic effect of Rheb1 controls differentiation and mediates mTORC1-dependent myelination in brain.	MTOR OLIG1 CNP	7.12e-06	8	177	3	25411504
Pubmed	Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice.	ABCC5 ABCC6 ABCC12	7.12e-06	8	177	3	15802388
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DGCR2 CAD DDX31 ATRX MPDZ PFAS SRPRA UFL1 NCLN MPRIP MED4 PAXBP1 SBF1 UBR5 EHMT2 INF2 MRPS9 HNRNPA0 DLG1 MACF1 PNPLA8 TSC22D4	7.50e-06	1487	177	22	33957083
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CAD DDX31 TRIO DHX38 PFAS SRPRA CNNM1 KMT2D MED4 SBF1 TJP1 SVIL YLPM1 SLTM CPSF1 DLG1 TNS3 FBXW7	7.58e-06	1049	177	18	27880917
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	MRE11 CAD PFKFB3 MPRIP INF2 TJP1 SVIL YLPM1 SAFB2 HNRNPA0 CPSF1 DLG1 MACF1 CNP	8.05e-06	660	177	14	32780723
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	MRE11 ATRX CLASP1 AAK1 UFL1 KMT2D PAXBP1 BRAF SVIL YLPM1 SAFB2 CPSF1 GIGYF2 DLG1 SPEN	1.11e-05	774	177	15	15302935
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	MRE11 TTLL3 ATRX DHX38 SMC6 ZCCHC2 PPCS SBNO2 PAXBP1 SCAP BRAF INF2 SLTM SAFB2 PIGW DLG1 MACF1 ARHGEF3	1.18e-05	1084	177	18	11544199
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CAD TRIO CLASP1 AAK1 MPRIP TENM4 SBF1 INF2 TJP1 AJM1 SVIL SLC4A10 FGA MRPS9 HNRNPA0 DLG1 MACF1 TSC22D4 BSN CNP CNTN1	1.39e-05	1431	177	21	37142655
Pubmed	Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	CLASP1 HECTD4 ADGRV1 NPHP4 PPP1R26 GIGYF2	1.43e-05	102	177	6	9734811
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	CAD DDX31 ATRX DHX38 HECTD4 MCM7 MPRIP SBF1 UBR5 YLPM1 NXF1	1.75e-05	440	177	11	34244565
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	NAGK CLASP1 CDH23 CCDC88B SLTM HNRNPA0 MACF1 SPEN NXF1 TNS3	1.78e-05	361	177	10	26167880
Pubmed	p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors.	SRPRA MPRIP BRAF EHMT2 TJP1 MRPS9 CNP	1.83e-05	159	177	7	30581152
Pubmed	The functional interactome landscape of the human histone deacetylase family.	CAD HDAC5 ING1 PAXBP1 UBR5 EHMT2 SVIL YLPM1 CPSF1	1.89e-05	289	177	9	23752268
Pubmed	MRE11 complex links RECQ5 helicase to sites of DNA damage.	MRE11 MCM7 UBR5	2.08e-05	11	177	3	19270065
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CAD FRMPD4 TRIO AAK1 SRPRA NCLN ANO8 TENM4 CELSR2 TJP1 AJM1 SLC4A10 MRPS9 HNRNPA0 DLG1 MACF1 BSN PCCB	2.27e-05	1139	177	18	36417873
Pubmed	Protein phosphatase 1α interacting proteins in the human brain.	FRMPD4 SH3RF2 YLPM1 CNP CNTN1	2.41e-05	67	177	5	22321011
Pubmed	Changes in the exocrine pancreas secondary to altered small intestinal function in the CF mouse.	CFTR DMBT1	2.58e-05	2	177	2	11557509
Pubmed	Mesenchymal Cell Invasion Requires Cooperative Regulation of Persistent Microtubule Growth by SLAIN2 and CLASP1.	SLAIN2 CLASP1	2.58e-05	2	177	2	27939686
Pubmed	Vault poly(ADP-ribose) polymerase is associated with mammalian telomerase and is dispensable for telomerase function and vault structure in vivo.	TEP1 PARP4	2.58e-05	2	177	2	15169895
Pubmed	Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor.	SPI1 PFKFB3	2.58e-05	2	177	2	29511345
Pubmed	The effect of NO-donors on chloride efflux, intracellular Ca(2+) concentration and mRNA expression of CFTR and ENaC in cystic fibrosis airway epithelial cells.	CFTR SCNN1A	2.58e-05	2	177	2	23523754
Pubmed	MUCLIN expression in the cystic fibrosis transmembrane conductance regulator knockout mouse.	CFTR DMBT1	2.58e-05	2	177	2	9247472
Pubmed	The cystic fibrosis transmembrane conductance regulator impedes proteolytic stimulation of the epithelial Na+ channel.	CFTR SCNN1A	2.58e-05	2	177	2	20709758
Pubmed	Mechanistic Target of Rapamycin Regulates the Oligodendrocyte Cytoskeleton during Myelination.	MTOR CNP	2.58e-05	2	177	2	32139584
Pubmed	Overexpression of G9a and MCM7 in oesophageal squamous cell carcinoma is associated with poor prognosis.	MCM7 EHMT2	2.58e-05	2	177	2	24805087
Pubmed	Increasing internodal distance in myelinated nerves accelerates nerve conduction to a flat maximum.	PRX CNP	2.58e-05	2	177	2	23022068
Pubmed	Diminished DYRK2 sensitizes hormone receptor-positive breast cancer to everolimus by the escape from degrading mTOR.	MTOR DYRK2	2.58e-05	2	177	2	27746162
Pubmed	Morphologic effects of epithelial ion channels on the mouse uterus: differences between raloxifene analog (LY117018) and estradiol treatments.	CFTR SCNN1A	2.58e-05	2	177	2	18456231
Pubmed	Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein.	MPDZ DLG1	2.58e-05	2	177	2	9192623
Pubmed	BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets.	BRAF FBXW7	2.58e-05	2	177	2	14507635
Pubmed	Expression of epithelial sodium channel (ENaC) and CFTR in the human epidermis and epidermal appendages.	CFTR SCNN1A	2.58e-05	2	177	2	28130590
Pubmed	PI3K-Akt-mTOR/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis.	PFKFB3 MTOR	2.58e-05	2	177	2	32051533
Pubmed	Increased susceptibility of vault poly(ADP-ribose) polymerase-deficient mice to carcinogen-induced tumorigenesis.	TEP1 PARP4	2.58e-05	2	177	2	16204055
Pubmed	mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma.	BRAF MTOR	2.58e-05	2	177	2	22549934
Pubmed	CFTR fails to inhibit the epithelial sodium channel ENaC expressed in Xenopus laevis oocytes.	CFTR SCNN1A	2.58e-05	2	177	2	15746174
Pubmed	The Mass1frings mutation underlies early onset hearing impairment in BUB/BnJ mice, a model for the auditory pathology of Usher syndrome IIC.	CDH23 ADGRV1	2.58e-05	2	177	2	15820310
Pubmed	MRP5 and MRP9 play a concerted role in male reproduction and mitochondrial function.	ABCC5 ABCC12	2.58e-05	2	177	2	35121660
Pubmed	Mapping the sites of localization of epithelial sodium channel (ENaC) and CFTR in segments of the mammalian epididymis.	CFTR SCNN1A	2.58e-05	2	177	2	30659401
Pubmed	Associations between INSR and MTOR polymorphisms in type 2 diabetes mellitus and diabetic nephropathy in a Northeast Chinese Han population.	INSR MTOR	2.58e-05	2	177	2	25867326
Pubmed	FBXW7 tumor suppressor regulation by dualspecificity tyrosine-regulated kinase 2.	DYRK2 FBXW7	2.58e-05	2	177	2	36934104
Pubmed	FBXW7 inactivation in a BrafV600E -driven mouse model leads to melanoma development.	BRAF FBXW7	2.58e-05	2	177	2	28581198
Pubmed	Arrest of myelination and reduced axon growth when Schwann cells lack mTOR.	MTOR CNP	2.58e-05	2	177	2	22302821
Pubmed	Enhancement of alveolar epithelial sodium channel activity with decreased cystic fibrosis transmembrane conductance regulator expression in mouse lung.	CFTR SCNN1A	2.58e-05	2	177	2	21743028
Pubmed	CFTR-adenylyl cyclase I association responsible for UTP activation of CFTR in well-differentiated primary human bronchial cell cultures.	CFTR ADCY1	2.58e-05	2	177	2	20554763
Pubmed	Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells.	BRAF FBXW7	2.58e-05	2	177	2	32907612
Pubmed	BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors.	BRAF MTOR	2.58e-05	2	177	2	23941441
Pubmed	Increased cystic fibrosis transmembrane conductance regulators expression and decreased epithelial sodium channel alpha subunits expression in early abortion: findings from a mouse model and clinical cases of abortion.	CFTR SCNN1A	2.58e-05	2	177	2	24914548
Pubmed	Prostasin-dependent activation of epithelial Na+ channels by low plasmin concentrations.	PRSS8 SCNN1A	2.58e-05	2	177	2	19793956
Pubmed	mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib.	BRAF MTOR	2.58e-05	2	177	2	26284586
Pubmed	Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CAD.	CAD DHODH	2.58e-05	2	177	2	33771897
Pubmed	Role of PFKFB3 and CD163 in Oral Squamous Cell Carcinoma Angiogenesis.	PFKFB3 CD163	2.58e-05	2	177	2	31209811
Pubmed	Phosphodiesterase 8A Regulates CFTR Activity in Airway Epithelial Cells.	PDE8A CFTR	2.58e-05	2	177	2	34936285
Pubmed	Mutations of the serine protease CAP1/Prss8 lead to reduced embryonic viability, skin defects, and decreased ENaC activity.	PRSS8 SCNN1A	2.58e-05	2	177	2	22705055
Pubmed	Colon-specific deletion of epithelial sodium channel causes sodium loss and aldosterone resistance.	PRSS8 SCNN1A	2.58e-05	2	177	2	24480829
Pubmed	Regulation of BRAF protein stability by a negative feedback loop involving the MEK-ERK pathway but not the FBXW7 tumour suppressor.	BRAF FBXW7	2.58e-05	2	177	2	26898828
Pubmed	Myelinating Schwann cells ensheath multiple axons in the absence of E3 ligase component Fbxw7.	MTOR FBXW7	2.58e-05	2	177	2	31278268
Pubmed	FBW7 Regulates the Autophagy Signal in Mesangial Cells Induced by High Glucose.	MTOR FBXW7	2.58e-05	2	177	2	31119177
Pubmed	Regulation of the epithelial sodium channel by serine proteases in human airways.	PRSS8 SCNN1A	2.58e-05	2	177	2	11756432
Pubmed	mTOR up-regulation of PFKFB3 is essential for acute myeloid leukemia cell survival.	PFKFB3 MTOR	2.58e-05	2	177	2	28082200
Pubmed	Temporal mTOR inhibition protects Fbxw7-deficient mice from radiation-induced tumor development.	MTOR FBXW7	2.58e-05	2	177	2	23454868
Pubmed	RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth.	BRAF MTOR	2.58e-05	2	177	2	22797077
Pubmed	BRAF gene alterations and enhanced mammalian target of rapamycin signaling in gangliogliomas.	BRAF MTOR	2.58e-05	2	177	2	28879901
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	IRF2BP1 DNAH2 NCLN DNAH7 ZFAND4 ABCC6 PARP4 KMT2D DNAH12 MRPS9 WDR86 BSN SPEN	2.60e-05	638	177	13	31182584
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SLAIN2 MRE11 CAD MPDZ MCM7 MPRIP KMT2D TJP1 YLPM1 GIGYF2 DLG1 SPEN	2.72e-05	549	177	12	38280479
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	VWA5B2 FRAT1 DNAH2 ABCC5 KIRREL2 DNAH7 BSN TNS3	2.77e-05	233	177	8	37704626
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	FLG CAD IRF2BP1 SMC6 DNAH2 PFAS EMILIN1 SCAP UBR5 EHMT2 SAFB2 CPSF1 DMBT1 NXF1	3.50e-05	754	177	14	35906200
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH2 DNAH7 DNAH12	4.53e-05	14	177	3	9373155
Interaction	TOP3B interactions	VWA5B2 DGCR2 SPIRE2 ANKS6 CAD TRIO NLRX1 HECTD4 PEX6 PFAS NCLN TEP1 NPHP4 ZBTB42 ADGRA2 BTN3A2 ANO8 SBNO2 MPRIP PPP1R26 RHPN1 KMT2D SCAP CELSR2 SBF1 INF2 MTOR CHD5 SVIL SAFB2 HNRNPA0 CPSF1 PIGW SH3BP5L SPEN PLXNA1	1.14e-08	1470	175	36	int:TOP3B
Interaction	YWHAH interactions	SLAIN2 SPIRE2 HDAC5 TRIO CLASP1 ING1 CFTR DHX38 HECTD4 AAK1 MPDZ PFKFB3 LARP1B DNAH7 MPRIP MAST4 BRAF SBF1 TJP1 MTOR PLEKHG3 SVIL MEPCE GIGYF2 MACF1 SH3BP5L TSC22D4 TNS3	3.00e-07	1102	175	28	int:YWHAH
Interaction	YWHAQ interactions	SPIRE2 CAD ZBTB17 HDAC5 CLASP1 ING1 CFTR HECTD4 AAK1 UFL1 TUT1 PFKFB3 LARP1B DNAH7 MPRIP MAST4 BRAF SBF1 TJP1 MTOR PLEKHG3 SVIL MEPCE FGA MACF1 SH3BP5L TNS3 FBXW7	4.01e-07	1118	175	28	int:YWHAQ
Interaction	FBXW7 interactions	FLG MRE11 CAD SPI1 CLASP1 MCM7 UFL1 CAVIN3 NCLN MPRIP USP2 KMT2D MED4 BRAF EHMT2 TJP1 MTOR FGA MRPS9 HNRNPA0 CPSF1 GIGYF2 MACF1 TSC22D4 NXF1 CNP DYRK2 FBXW7	2.07e-06	1215	175	28	int:FBXW7
Interaction	C2CD4B interactions	FAT3 MPDZ ADGRV1 CELSR2 SVIL MACF1	2.11e-06	44	175	6	int:C2CD4B
Interaction	YWHAZ interactions	SPIRE2 CAD HDAC5 CLASP1 ING1 CFTR HECTD4 AAK1 PFAS SRPRA UFL1 PFKFB3 MPRIP KRT24 MAST4 BRAF SBF1 TJP1 MTOR PLEKHG3 SVIL MEPCE GIGYF2 MACF1 SH3BP5L TSC22D4 NXF1 CNP FBXW7	3.37e-06	1319	175	29	int:YWHAZ
Interaction	YWHAG interactions	SLAIN2 SPIRE2 CAD HDAC5 CLASP1 ING1 CFTR HECTD4 AAK1 MPDZ PFKFB3 LARP1B DNAH7 MPRIP MAST4 BRAF SBF1 TJP1 MTOR PLEKHG3 SVIL MEPCE GIGYF2 MACF1 SH3BP5L TSC22D4 TNS3 FBXW7	3.47e-06	1248	175	28	int:YWHAG
Interaction	YWHAB interactions	SLAIN2 SPIRE2 HDAC5 CLASP1 ING1 CFTR INSR HECTD4 AAK1 PFKFB3 MPRIP MAST4 BRAF TJP1 MTOR PLEKHG3 SVIL MEPCE GIGYF2 MACF1 SH3BP5L TNS3 FBXW7	2.40e-05	1014	175	23	int:YWHAB
Interaction	RHOF interactions	CAD DDX31 PDE8A MPDZ ABCC5 SRPRA NCLN BTN3A2 MPRIP SBF1 INF2 TJP1 MTOR DLG1 MACF1 PLXNA1 NXF1 TNS3	2.40e-05	673	175	18	int:RHOF
Interaction	MKRN2 interactions	ATRX TRIO UFL1 LARP1B ADCY1 CELSR2 EHMT2 MTOR DLG1 MACF1 ATF1 NXF1 CNTN1	3.33e-05	385	175	13	int:MKRN2
Interaction	CPSF3 interactions	MRE11 UFL1 TUT1 MED4 TJP1 CPSF1 NXF1 FBXW7	4.19e-05	146	175	8	int:CPSF3
Interaction	CALM3 interactions	ANKS6 ATRX CFTR INSR MPRIP INF2 TJP1 PLEKHG3 SVIL DLG1 NXF1 FBXW7	4.79e-05	343	175	12	int:CALM3
Interaction	GFI1 interactions	ZBTB17 SPI1 EHMT2 FBXW7	5.10e-05	24	175	4	int:GFI1
Interaction	MAD2L1 interactions	PRSS8 CAD INSR UBR5 EHMT2 RHOBTB2 ANAPC2 MEPCE MACF1 TSC22D4	7.35e-05	252	175	10	int:MAD2L1
Interaction	MEN1 interactions	MRE11 KATNAL2 DDX31 ATRX CFTR DHX38 SMC6 NPM3 KMT2D PAXBP1 UBR5 EHMT2 TJP1 YLPM1 MEPCE SLTM SAFB2 MRPS9 CPSF1 GIGYF2 KAZN SPEN	8.76e-05	1029	175	22	int:MEN1
Interaction	SPRING1 interactions	RAD51D CAD ATRX UFL1 MED4 SCAP EHMT2 YLPM1 CPSF1 GIGYF2	9.23e-05	259	175	10	int:SPRING1
Interaction	DDX41 interactions	CFTR UFL1 PAXBP1 UBR5 MEPCE SPEN NXF1 FBXW7	1.04e-04	166	175	8	int:DDX41
Interaction	SAA1 interactions	MPRIP PLEKHG3 YLPM1 SLTM SAFB2	1.05e-04	54	175	5	int:SAA1
GeneFamily	ATP binding cassette subfamily C	CFTR ABCC5 ABCC6 ABCC12	1.44e-06	13	124	4	807
GeneFamily	PDZ domain containing	FRMPD4 MPDZ PRX RHPN1 MAST4 TJP1 DLG1	8.56e-05	152	124	7	1220
GeneFamily	Dyneins, axonemal	DNAH2 DNAH7 DNAH12	2.00e-04	17	124	3	536
GeneFamily	Cadherin related	FAT3 CDH23 CLSTN2	2.00e-04	17	124	3	24
GeneFamily	6-phosphofructo-2-kinases/fructose-2,6-biphosphatases	PFKFB1 PFKFB3	2.77e-04	4	124	2	1077
GeneFamily	EMI domain containing	EMILIN3 EMILIN1	9.58e-04	7	124	2	540
GeneFamily	EF-hand domain containing\|S100 fused type protein family	FLG CRNN	9.58e-04	7	124	2	1350
Coexpression	GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_UP	MPDZ MCM7 CLSTN2 SH3RF2 PLEKHG3 CNGB3 BSN DHTKD1 CNTN1	9.76e-07	152	177	9	M405
CoexpressionAtlas	e11.5_Emin_MedNasl_SingCel_top-relative-expression-ranked_500_1	PRSS8 TRIO SIX6 HNRNPA0	1.02e-05	17	177	4	Facebase_ST1_e11.5_Emin_MedNasl_SingCel_500_1
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#3	SLAIN2 CABP2 CPNE9 ZBTB17 DNAH2 EMILIN3 IL17RC ZFAND4 ABCB8 CNTN3	3.25e-05	238	177	10	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K3
ToppCell	ILEUM-inflamed-(6)_ILC-(6)_ILC3\|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	AFF3 C20orf204 PFKFB3 NPM3 MAST4 SVIL SLC4A10 HNRNPA0 TNS3	1.09e-07	199	177	9	02879df850b0c72b57d7b22cfc43f3407e182dcb
ToppCell	primary_visual_cortex-Non-neuronal-oligodendrocyte\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PNLIP PDE8A ADGRV1 PLEKHG3 TSC22D4 OLIG1 CNP TNS3	1.44e-07	148	177	8	44128692824ca419fface0af41099c17135933ce
ToppCell	primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PNLIP PDE8A ADGRV1 PLEKHG3 TSC22D4 OLIG1 CNP TNS3	1.44e-07	148	177	8	d60f93311cfa718d026a0dbf61771bbbcbb79146
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF3 KBTBD2 PRX FRY ARHGEF3 PLXNA1 TNS3 DYRK2	9.29e-07	189	177	8	09dd2b3d89416192e84abe302a6237b8f3fdcb6e
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	CFTR AFF3 ADGRV1 ABCC6 MAST4 RHOBTB2 SCNN1A DMBT1	1.01e-06	191	177	8	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	ILEUM-inflamed-(6)_ILC3\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	AFF3 C20orf204 PFKFB3 ZCCHC2 MAST4 SVIL SLC4A10 TNS3	1.17e-06	195	177	8	c6968da7d2b60c2163e1ff0ffa41340e1ec1d2ed
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWA5B2 DNAH2 MPDZ ODAD4 CLSTN2 DNAH7 RHPN1 DNAH12	1.27e-06	197	177	8	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRMPD4 AFF3 FRY TENM4 CHD5 SLC4A10 CNTN1 FBXW7	1.32e-06	198	177	8	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	ILEUM-non-inflamed-(6)_ILC-(6)_ILC3\|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	AFF3 C20orf204 NPM3 MAST4 SVIL SLC4A10 HNRNPA0 TNS3	1.37e-06	199	177	8	ba144739f65560207303c0143e8de1e86922bebb
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	DDX31 CFTR DNAH2 PEX6 KIRREL2 DNAH7 RNF6 PLEKHG3	1.42e-06	200	177	8	6b7314c425f6b40f1301dd39cc02b0436e96a2ec
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PRSS8 CFTR ADGRV1 RHOBTB2 C11orf96 SCNN1A FGA DMBT1	1.42e-06	200	177	8	b535323e18d9fb0dde1e0026df142c831e48c29f
ToppCell	primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Serpinb1a\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDE8A ADGRV1 PLEKHG3 TSC22D4 OLIG1 CNP TNS3	1.43e-06	139	177	7	789edd3c98e7c5c1cc402c780fded9a9dfd1dfb8
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte-Oligo\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PNLIP PDE8A ADGRV1 PLEKHG3 TSC22D4 OLIG1 CNP	2.37e-06	150	177	7	b30f52b94ce772632a1f2f5e0837db876cf92651
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PNLIP PDE8A ADGRV1 PLEKHG3 TSC22D4 OLIG1 CNP	2.37e-06	150	177	7	05b9a9cbc5a95cdaf45d5f173e132acd4da9aa8a
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 CFTR MUC19 ADGRV1 PKHD1L1 CNTN3 ABCC12	3.64e-06	160	177	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 CFTR MUC19 ADGRV1 PKHD1L1 CNTN3 ABCC12	3.64e-06	160	177	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRSS8 ANKS6 PEX6 NCLN SBNO2 BNIPL CNTN3	4.83e-06	167	177	7	d1a13d6ada572d8ddb2da95e6e122d2b705fad7f
ToppCell	10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	AFF3 CNNM1 FRY MAST4 SVIL SLC4A10 TNS3	5.43e-06	170	177	7	97df5ffb328196c46568975d2d97722bcc753bf5
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTLL3 ABCC5 APOBR ZBTB42 SVIL SCNN1A GIGYF2	6.09e-06	173	177	7	c31076c725f4cd912c56903592a2d9356ae59f54
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTLL3 ABCC5 APOBR ZBTB42 SVIL SCNN1A GIGYF2	6.09e-06	173	177	7	a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	AADAC SPIRE2 CFTR ADGRV1 ABCC6 MAST4 BNIPL	7.61e-06	179	177	7	815b959ce8721c5ded70c0ca6e318dafc691746e
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 FAT3 CFTR ADGRV1 PKHD1L1 TENM4 CNTN1	9.10e-06	184	177	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	CFTR AFF3 ADGRV1 MAST4 RHOBTB2 SCNN1A DMBT1	9.10e-06	184	177	7	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 FAT3 CFTR ADGRV1 PKHD1L1 TENM4 CNTN1	9.10e-06	184	177	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRMPD4 FAT3 CFTR ADGRV1 PKHD1L1 TENM4 CNTN1	9.10e-06	184	177	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-ILC3\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AFF3 C20orf204 PFKFB3 FRY SLC4A10 HNRNPA0 WDR86	9.43e-06	185	177	7	7d6954bb04368ec62b284ba6c3021a15fbdfdee6
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	CFTR INSR ADGRV1 MAST4 BNIPL CNTN3 WDR86	1.01e-05	187	177	7	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	CFTR AFF3 ADGRV1 MAST4 RHOBTB2 KAZN DMBT1	1.08e-05	189	177	7	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	CFTR INSR ABCC5 ADGRV1 MAST4 CNTN3 WDR86	1.12e-05	190	177	7	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CFTR AFF3 ADGRV1 ABCC6 RHOBTB2 SCNN1A DMBT1	1.12e-05	190	177	7	27a1a86620fe9b5ee930d388b32352206485e6d0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO FAT3 PFKFB3 DNAH7 PARP4 KAZN TNS3	1.16e-05	191	177	7	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	ILEUM-non-inflamed-(6)_ILC3\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	AFF3 C20orf204 SVIL SLTM SLC4A10 HNRNPA0 TNS3	1.16e-05	191	177	7	6eaf72b41084404bee0db04e4605db745a74995f
ToppCell	(7)_Epithelial-C_(AT2)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CFTR RHOBTB2 C11orf96 SCNN1A FGA DMBT1 CNTN1	1.24e-05	193	177	7	a3ca6ab20c8de260e410ddc14d3d202f28b9d6c2
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 ADCY1 CNNM1 TENM4 CELSR2 CHD5 BSN	1.24e-05	193	177	7	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 ADCY1 CNNM1 TENM4 CELSR2 CHD5 BSN	1.24e-05	193	177	7	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 ADCY1 CNNM1 TENM4 CELSR2 CHD5 BSN	1.24e-05	193	177	7	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	ILEUM-inflamed-(6)_ILC\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CLASP1 AFF3 C20orf204 PFKFB3 ZCCHC2 SVIL SLC4A10	1.28e-05	194	177	7	4d51d49366c34ff1241770b4acc0167a43b3155a
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FRMPD4 FAT3 EMILIN3 CAVIN3 EMILIN1 TENM4 PCOLCE	1.33e-05	195	177	7	ec12cfb2fce44cc2de4e198ef5af075e626f0329
ToppCell	(7)_Epithelial-A_(AT2)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	AADAC PRSS8 CFTR RHOBTB2 C11orf96 DMBT1 CNTN1	1.33e-05	195	177	7	c9a6c65ee18d83bf34a4713d306a6e30db1325c2
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SPI1 FAT3 MUC19 ADGRV1 ADCY1 CNTN3 ABCC12	1.33e-05	195	177	7	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SPI1 FAT3 MUC19 ADGRV1 ADCY1 CNTN3 ABCC12	1.33e-05	195	177	7	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE9 FRMPD4 FAT3 CLSTN2 SLC4A10 DLG1 FBXW7	1.33e-05	195	177	7	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPI1 PRX FRY TENM4 C7orf25 OLIG1	1.36e-05	130	177	6	92913960e4367261ba08a405b61a421bc5e18169
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FAT3 AFF3 MAST4 CNTN3 MACF1 KAZN CNTN1	1.42e-05	197	177	7	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FAT3 AFF3 MAST4 CNTN3 MACF1 KAZN CNTN1	1.42e-05	197	177	7	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRMPD4 AFF3 FRY CHD5 SLC4A10 KAZN CNTN1	1.46e-05	198	177	7	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRMPD4 AFF3 FRY CHD5 SLC4A10 KAZN CNTN1	1.46e-05	198	177	7	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ATRX TRIO MPDZ MAST4 UBR5 TJP1 MACF1	1.56e-05	200	177	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	FRMPD4 AFF3 AAK1 FRY CHD5 SLC4A10 CNTN1	1.56e-05	200	177	7	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Sigmoid-ILC\|Sigmoid / Region, Cell class and subclass	AFF3 AAK1 PFKFB3 RHPN1 FRY SVIL SLC4A10	1.56e-05	200	177	7	dfb06821f1019833f5d81f9c93808219b5fef407
ToppCell	Sigmoid-(3)_ILC\|Sigmoid / shred on region, Cell_type, and subtype	AFF3 AAK1 PFKFB3 RHPN1 FRY SVIL SLC4A10	1.56e-05	200	177	7	a7326c43987a5eb4f4f5b48c4252cf4870432e5d
ToppCell	Sigmoid-(3)_ILC-(30)_ILC\|Sigmoid / shred on region, Cell_type, and subtype	AFF3 AAK1 PFKFB3 RHPN1 FRY SVIL SLC4A10	1.56e-05	200	177	7	c39de94623383da7b2b260eb016ddaa5da7f4350
ToppCell	Sigmoid-ILC-ILC\|Sigmoid / Region, Cell class and subclass	AFF3 AAK1 PFKFB3 RHPN1 FRY SVIL SLC4A10	1.56e-05	200	177	7	4ac1e6d7f358003e2448eb69e545772cd261c55f
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	ADCY1 MAST4 CHD5 TSC22D4 OLIG1 CNTN1 FBXW7	1.56e-05	200	177	7	5c7263c862093ad9dbc81d06b16b6f74e8a6b634
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Serpinb1a\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDE8A ADGRV1 PLEKHG3 TSC22D4 OLIG1 CNP	1.83e-05	137	177	6	ca8fdbe66a854e6283b22179ec9359ea9e86cd8e
ToppCell	PND01-03-samps-Myeloid-Macrophage-macrophage-B\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	SPIRE2 SPI1 ZFAND4 DNAH12 DMBT1 RUFY4	3.28e-05	152	177	6	5ce8920aedd39a4daf7082153b5e213707c14227
ToppCell	10x5'-blood-Lymphocytic_T_CD8-Trm_gut_CD8\|blood / Manually curated celltypes from each tissue	FMO4 RHPN1 DHODH PIGW ARHGEF3 PCCB	3.53e-05	154	177	6	c77a02df403358361aca86c679d5c43a64ff2f7f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC19 ADGRV1 MAST4 SH3RF2 SCNN1A WDR86	4.22e-05	159	177	6	8680b054622f573a82b1625fb93c2d5db81d1034
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FRMPD4 FAT3 ADGRV1 PKHD1L1 CNTN3 DMBT1	4.69e-05	162	177	6	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CLASP1 USP2 TENM4 SIGLEC11 OLIG1 CNP	6.75e-05	173	177	6	7a3115e7cf7e2f345192cde0656a7f0193594a5f
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS8 CFTR SCNN1A FGA MUC2 URAD	6.97e-05	174	177	6	e7cca4b6a3935fad61cf2a3d9984ab1ffa1a9447
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS8 CFTR SCNN1A FGA MUC2 URAD	6.97e-05	174	177	6	ad5b56f0ace6455c033834b931ec870cc0dc9290
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPI1 TRIO ZCCHC2 APOBR CD163 TNS3	6.97e-05	174	177	6	d5c22b43531414951666ee7542a66ed9380e2d14
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	KATNAL2 TTLL3 CFTR UFL1 ZBTB42	7.15e-05	108	177	5	ba83418023d9d296b0edd4c4e1832a33bc9b3b69
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))--\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	KATNAL2 TTLL3 CFTR UFL1 ZBTB42	7.15e-05	108	177	5	a93a427ab16628c86db3bb17bfecf801f56ce270
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	KATNAL2 TTLL3 CFTR UFL1 ZBTB42	7.15e-05	108	177	5	673da75b24218557d01ee461a13c426040da74b9
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	IRF2BP1 ZNF831 CDAN1 MAST4 SCNN1A CRNN	7.19e-05	175	177	6	f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCell	Thalamus-Neuronal-Excitatory\|Thalamus / BrainAtlas - Mouse McCarroll V32	CPNE9 FRMPD4 CFTR CLSTN2 BSN FBXW7	7.42e-05	176	177	6	d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FRMPD4 MCM7 ST8SIA2 MACF1 DHTKD1 TNS3	7.42e-05	176	177	6	cb8fd56a4f935cdda19d7ab43382cdda7c307667
ToppCell	Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.Zbtb20_(Ventral_Hippocampus)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ZNF831 CCDC88B SCNN1A FGA DIO3	7.81e-05	110	177	5	ff196c71aa2a21cdd812958bd163fa6b91bd2352
ToppCell	Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ZNF831 CCDC88B SCNN1A FGA DIO3	7.81e-05	110	177	5	438bf761ab0a25e3dc9244c23ae2c2d68a169c7f
ToppCell	Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.Zbtb20_(Ventral_Hippocampus)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ZNF831 CCDC88B SCNN1A FGA DIO3	7.81e-05	110	177	5	46635a130453c2fa304f0e09561b2a267c9ceb31
ToppCell	Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ZNF831 CCDC88B SCNN1A FGA DIO3	7.81e-05	110	177	5	3639fb5fc02eca509cb220295bc3e6064c23baab
ToppCell	390C-Epithelial_cells-Epithelial-B_(AT2)\|390C / Donor, Lineage, Cell class and subclass (all cells)	CFTR RHOBTB2 C11orf96 SCNN1A FGA DMBT1	8.15e-05	179	177	6	466da2bc3bfc534ffe111c8c28ece7a3cfa08051
ToppCell	390C-Epithelial_cells-Epithelial-B_(AT2)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	CFTR RHOBTB2 C11orf96 SCNN1A FGA DMBT1	8.15e-05	179	177	6	f4bdebb77d39e63160fbf3a85a340ce4d52b7cfd
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAGK SPI1 TEP1 APOBR MEPCE OLIG1	8.15e-05	179	177	6	61dbfc1b9b0344c06a68142c181cd62993556a67
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFTR ABCC5 ADGRV1 MAST4 BNIPL CNTN3	8.40e-05	180	177	6	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	IIH-Treg-proli_CD4\|IIH / Condition, Cell_class and T cell subcluster	PEX6 MAST4 MTOR SH3BP5L NXF1 PCOLCE	8.93e-05	182	177	6	5c7d02da9ca2bca49db9832704b6894dfaa08a71
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KATNAL2 ADGRV1 USP2 MAST4 KAZN ARHGEF3	8.93e-05	182	177	6	041bc819e6cf2618bf86bce8dfe2df673f392ba3
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRX CELSR2 FGA TSC22D4 TNS3 FBXW7	8.93e-05	182	177	6	c00e503f442d44fbae73c5e2dc85be69e294e67a
ToppCell	facs-Trachea-24m-Epithelial-glandular_epithelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPIRE2 PRSS8 CFTR CLSTN2 RHPN1 BNIPL	9.48e-05	184	177	6	61caaa31975e05c9a6512079c791fed5a9e2d39f
ToppCell	facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPIRE2 PRSS8 CFTR CLSTN2 RHPN1 BNIPL	9.48e-05	184	177	6	03da0f0f89f1ca5a3ccca1e22972f3129464e68e
ToppCell	facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPIRE2 PRSS8 CFTR CLSTN2 RHPN1 BNIPL	9.48e-05	184	177	6	9ed2a65a4ca0ebbbb89ace61027522f93369843d
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	AADAC CFTR ADGRV1 ABCC6 MAST4 RHOBTB2	1.01e-04	186	177	6	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SPI1 MUC19 ADGRV1 APOBR TENM4 SIGLEC11	1.01e-04	186	177	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIRE2 PRX CNNM1 CHD5 OLIG1 CNP	1.04e-04	187	177	6	16e55d802fc4e71878305e61ad03806aabd59537
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KATNAL2 ADGRV1 USP2 SCNN1A KAZN CNTN1	1.04e-04	187	177	6	7ea8731288e2a99f45e3958590ee1d76f49ae888
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CFTR CLSTN2 ADGRV1 TENM4 MAST4 KAZN	1.07e-04	188	177	6	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	368C-Epithelial_cells-Epithelial-E_(AT2)\|368C / Donor, Lineage, Cell class and subclass (all cells)	PRSS8 ADGRV1 ABCC6 RHOBTB2 SCNN1A DMBT1	1.10e-04	189	177	6	6f2322d017b74a1757c81d6e06f50ead8c3dd0cc
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FAT3 PFKFB3 DNAH7 CNNM1 PARP4 TNS3	1.10e-04	189	177	6	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	368C-Epithelial_cells-Epithelial-E_(AT2)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	PRSS8 ADGRV1 ABCC6 RHOBTB2 SCNN1A DMBT1	1.10e-04	189	177	6	926b5fa3064b501a57ba78583e8af33532add455
ToppCell	368C-Epithelial_cells\|368C / Donor, Lineage, Cell class and subclass (all cells)	PRSS8 ADGRV1 ABCC6 RHOBTB2 SCNN1A DMBT1	1.13e-04	190	177	6	459811e88d3001816c2d89034e0921c24918c17f
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFTR ADGRV1 ABCC6 MAST4 RHOBTB2 SCNN1A	1.16e-04	191	177	6	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FAT3 CAVIN3 TJP1 ST8SIA2 CNTN1 PCOLCE	1.16e-04	191	177	6	98b907f8fa024cf32e462323b782c5a371327bbd
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	CFTR AFF3 ADGRV1 MAST4 RHOBTB2 DMBT1	1.20e-04	192	177	6	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFTR AFF3 ADGRV1 MAST4 RHOBTB2 SCNN1A	1.20e-04	192	177	6	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	AFF3 ADGRV1 ABCC6 MAST4 RHOBTB2 SCNN1A	1.20e-04	192	177	6	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	PDE8A TRIO INSR MAST4 SVIL MACF1	1.20e-04	192	177	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFTR AFF3 ADGRV1 MAST4 RHOBTB2 DMBT1	1.23e-04	193	177	6	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 FAT3 CLSTN2 TENM4 CHD5 BSN	1.23e-04	193	177	6	461919ab422bc9d1fcff7a3a4757c75239041d7e
Drug	SC-560; Up 200; 10uM; MCF7; HT_HG-U133A	MPDZ ZCCHC2 NPHP4 TRIM23 UBR5 TJP1 YLPM1 SAFB2 ARHGEF3 DYRK2 FBXW7	3.67e-07	195	176	11	6913_UP
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A	DGCR2 ZBTB17 TRIO TEP1 NPHP4 SBNO2 MAST4 BRAF SBF1 SVIL TSC22D4	4.27e-07	198	176	11	7366_DN
Drug	Famotidine [76824-35-6]; Up 200; 11.8uM; PC3; HG-U133A	HDAC5 AAK1 UFL1 NPHP4 SBNO2 UBR5 ANAPC2 YLPM1 DHTKD1 DYRK2	2.98e-06	195	176	10	1946_UP
Drug	(d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; HL60; HT_HG-U133A	ING1 TUT1 SBNO2 CNNM1 CELSR2 BRAF PLEKHG3 RHOBTB2 KAZN CNTN1	2.98e-06	195	176	10	2163_DN
Drug	Josamycin [16846-24-5]; Down 200; 4.8uM; PC3; HG-U133A	DDX31 IRF2BP1 ING1 SRPRA NCLN NPHP4 MAST4 PLEKHG3 MACF1 DYRK2	3.58e-06	199	176	10	1950_DN
Drug	Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A	DGCR2 IRF2BP1 TRIO DHX38 PPP1R26 INF2 MTOR C7orf25 YLPM1 SAFB2	3.58e-06	199	176	10	7009_DN
Drug	Nortriptyline hydrochloride [894-71-3]; Down 200; 13.4uM; HL60; HT_HG-U133A	ING1 PEX6 CELSR2 BRAF SBF1 C7orf25 PLEKHG3 SAFB2 MACF1 PLXNA1	3.58e-06	199	176	10	2391_DN
Drug	retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A	PFKFB3 NPM3 RNF6 SCNN1A KAZN CNP TNS3 DYRK2 FBXW7	7.64e-06	171	176	9	5208_UP
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A	DDX31 ING1 FRAT1 PFAS TUT1 TRIM23 MAST4 C7orf25 SVIL	2.10e-05	194	176	9	5216_DN
Drug	Hesperidin [520-26-3]; Down 200; 6.6uM; HL60; HT_HG-U133A	NLRX1 PEX6 PLEKHG3 TPP1 RHOBTB2 ANAPC2 CPSF1 CNP FBXW7	2.28e-05	196	176	9	1294_DN
Drug	Syrosingopine [84-36-6]; Down 200; 6uM; PC3; HT_HG-U133A	DGCR2 DDX31 SBF1 RHOBTB2 ANAPC2 YLPM1 MEPCE SAFB2 KAZN	2.28e-05	196	176	9	5733_DN
Drug	Gliquidone [33342-05-1]; Down 200; 7.6uM; PC3; HT_HG-U133A	RAD51D HDAC5 FRAT1 NLRX1 BTN3A2 SBNO2 SBF1 HNRNPA0 PCOLCE	2.37e-05	197	176	9	7301_DN
Drug	Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; MCF7; HT_HG-U133A	DGCR2 HDAC5 IRF2BP1 ATRX TRIO TUT1 CNGB3 SAFB2 PLXNA1	2.37e-05	197	176	9	1541_DN
Drug	Myosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A	ZBTB17 ADGRA2 MAST4 SBF1 RNF6 RHOBTB2 SAFB2 DMBT1 TSC22D4	2.47e-05	198	176	9	4293_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	DDX31 AAK1 MAST4 SBF1 INF2 MTOR PLEKHG3 CNGB3 FBXW7	2.47e-05	198	176	9	7177_DN
Drug	Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A	TEP1 ADCY1 SBNO2 CELSR2 SBF1 INF2 RHOBTB2 SVIL SAFB2	2.47e-05	198	176	9	4592_DN
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	DGCR2 TRIO ADCY1 SBNO2 BRAF YLPM1 DLG1 MACF1 FBXW7	2.57e-05	199	176	9	3403_DN
Drug	Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; HL60; HG-U133A	FMO4 FRAT1 AAK1 APOBR BTN3A2 UBR5 SVIL YLPM1 DYRK2	2.67e-05	200	176	9	2027_DN
Drug	PbTx-2	CFTR ABCB8 ST8SIA2 SCNN1A	4.52e-05	26	176	4	CID000002432
Drug	Capobenic acid	ABCC6 UBR5 DHODH YLPM1	5.27e-05	27	176	4	CID000030627
Drug	Papac	DGCR2 INSR	5.94e-05	2	176	2	CID003760025
Drug	Texas Red	CFTR ABCC5 ABCC6 CNP	6.11e-05	28	176	4	CID000452705
Drug	retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A	AAK1 PFKFB3 PLEKHG3 SCNN1A KAZN PLXNA1 CNP DYRK2	7.59e-05	178	176	8	1636_UP
Drug	Phleomycin	MRE11 AADAC SLC26A1 UBR5	8.08e-05	30	176	4	CID000072511
Drug	EGEEA	CLSTN2 CNTN3 NXF1	9.49e-05	12	176	3	CID000008095
Drug	6-methylpurine-2'-deoxyriboside	AADAC SPI1 ABCC5 ABCC6 ABCG8	1.09e-04	61	176	5	CID000097184
Drug	genistein; Down 200; 10uM; HL60; HT_HG-U133A	RAD51D HDAC5 NLRX1 AAK1 SBF1 SVIL DHODH SAFB2	1.11e-04	188	176	8	1176_DN
Drug	Cyclosporin A [59865-13-3]; Up 200; 3.4uM; HL60; HT_HG-U133A	SRPRA BTN3A2 BRAF SBF1 TPP1 TSC22D4 PLXNA1 DYRK2	1.15e-04	189	176	8	1331_UP
Drug	harmol sulfate	ABCC5 ABCC6 CNTN3	1.23e-04	13	176	3	CID005488302
Drug	17-AAG; Down 200; 1uM; ssMCF7; HG-U133A	DGCR2 MRE11 TRIO PFAS PFKFB3 ADGRA2 TRIM23 YLPM1	1.24e-04	191	176	8	521_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A	IL17RC TUT1 TRIM23 NPM3 SBF1 RNF6 PLEKHG3 DYRK2	1.29e-04	192	176	8	5058_DN
Drug	0317956-0000 [391210-11-0]; Up 200; 1uM; MCF7; HT_HG-U133A	ZBTB17 IL17RC ADGRA2 TRIM23 NPM3 USP2 RNF6 CPSF1	1.29e-04	192	176	8	3858_UP
Drug	Levodopa [59-92-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A	DGCR2 TRIO ING1 SRPRA IL17RC TRIM23 RNF6 SAFB2	1.33e-04	193	176	8	4394_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A	TRIO IL17RC TEP1 SBNO2 MAST4 RNF6 DLG1 KAZN	1.33e-04	193	176	8	4338_DN
Drug	Simvastatin [79902-63-9]; Down 200; 9.6uM; PC3; HT_HG-U133A	TRIO TRIM23 SBNO2 CNNM1 RNF6 CNGB3 SAFB2 TSC22D4	1.38e-04	194	176	8	4244_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	RAD51D ING1 AFF3 MPDZ KAZN TSC22D4 PLXNA1 CNTN1	1.43e-04	195	176	8	2208_DN
Drug	Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A	CABP2 CLSTN2 ADCY1 SBNO2 KRT24 CHD5 CNGB3 SAFB2	1.43e-04	195	176	8	4705_UP
Drug	15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A	HDAC5 PFAS CLSTN2 SBNO2 CELSR2 CNGB3 YLPM1 CNP	1.43e-04	195	176	8	5591_DN
Drug	monastrol; Down 200; 100uM; MCF7; HG-U133A	MRE11 TRIO ING1 PFAS CLSTN2 PFKFB1 KAZN DYRK2	1.48e-04	196	176	8	610_DN
Drug	Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; PC3; HT_HG-U133A	RAD51D ZBTB17 ING1 TEP1 SBF1 INF2 RHOBTB2 DYRK2	1.48e-04	196	176	8	7312_DN
Drug	Mesalamine [89-57-6]; Up 200; 26.2uM; PC3; HT_HG-U133A	RAD51D PRSS8 FMO4 TRIM23 CELSR2 CNGB3 DHODH FBXW7	1.48e-04	196	176	8	5888_UP
Drug	Condelphine [7633-69-4]; Down 200; 8.8uM; HL60; HT_HG-U133A	ATRX NLRX1 SRPRA TEP1 TRIM23 RNF6 TPP1 DLG1	1.48e-04	196	176	8	2976_DN
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A	DGCR2 IRF2BP1 MPDZ SRPRA TEP1 MAST4 SBF1 KAZN	1.48e-04	196	176	8	3892_DN
Drug	Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	IRF2BP1 NLRX1 TRIM23 SBNO2 SBF1 RNF6 SAFB2 GTPBP3	1.48e-04	196	176	8	7234_DN
Drug	Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; PC3; HT_HG-U133A	TRIO NLRX1 INSR PEX6 TRIM23 MAST4 RHOBTB2 FBXW7	1.48e-04	196	176	8	7128_UP
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A	TRIO PEX6 SBNO2 PPP1R26 MAST4 RHOBTB2 CNGB3 FBXW7	1.48e-04	196	176	8	7314_DN
Drug	ciguatoxin	SPI1 ADGRA2 ABCB8 SCNN1A	1.50e-04	35	176	4	CID005311333
Drug	Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	ATRX ING1 FRAT1 AAK1 TRIM23 RNF6 CNGB3 FBXW7	1.53e-04	197	176	8	5341_DN
Drug	Methiazole; Down 200; 15uM; PC3; HT_HG-U133A	DDX31 HDAC5 TUT1 TEP1 MAST4 INF2 MACF1 FBXW7	1.53e-04	197	176	8	4532_DN
Drug	Pentylenetetrazole [54-95-5]; Down 200; 29uM; PC3; HT_HG-U133A	IRF2BP1 ING1 BTN3A2 MAST4 BRAF SBF1 DMBT1 PLXNA1	1.53e-04	197	176	8	2092_DN
Drug	Pivampicillin [33817-20-8]; Up 200; 8.6uM; PC3; HT_HG-U133A	FMO4 ZBTB17 CFTR NPHP4 CNNM1 CNGB3 DMBT1 FBXW7	1.53e-04	197	176	8	5046_UP
Drug	Nizatidine [76963-41-2]; Down 200; 12uM; MCF7; HT_HG-U133A	ZBTB17 HDAC5 NLRX1 SBNO2 NPM3 SBF1 PLEKHG3 CNGB3	1.53e-04	197	176	8	5406_DN
Drug	Cefotaxime sodium salt [64485-93-4]; Up 200; 8.4uM; HL60; HG-U133A	HDAC5 AAK1 YLPM1 SCNN1A ARHGEF3 CNP CNTN1 DYRK2	1.53e-04	197	176	8	1389_UP
Drug	Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A	PRSS8 ING1 SRPRA NPM3 RNF6 SVIL HNRNPA0 DLG1	1.53e-04	197	176	8	5337_DN
Drug	Allantoin [97-59-6]; Up 200; 25.2uM; HL60; HT_HG-U133A	DDX31 IL17RC TRIM23 SBNO2 INF2 C7orf25 TPP1 TSC22D4	1.53e-04	197	176	8	1842_UP
Drug	Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A	HDAC5 AAK1 TUT1 SBNO2 CELSR2 C7orf25 YLPM1 TSC22D4	1.53e-04	197	176	8	6359_DN
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A	DGCR2 CNNM1 SBF1 CNGB3 YLPM1 SAFB2 KAZN PLXNA1	1.53e-04	197	176	8	5746_DN
Drug	Od-T	CAD DHODH SPEN	1.55e-04	14	176	3	CID006102742
Drug	Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; PC3; HT_HG-U133A	DGCR2 DDX31 NLRX1 IL17RC ANAPC2 SAFB2 DLG1 DHTKD1	1.59e-04	198	176	8	5807_DN
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; PC3; HT_HG-U133A	RAD51D IRF2BP1 AAK1 PEX6 CNNM1 MTOR TPP1 RHOBTB2	1.59e-04	198	176	8	4546_DN
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A	ZBTB17 TUT1 TRIM23 SBNO2 NPM3 MAST4 SVIL YLPM1	1.59e-04	198	176	8	7168_DN
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; PC3; HT_HG-U133A	DGCR2 PRSS8 IRF2BP1 AAK1 IL17RC TEP1 DNAH7 RHOBTB2	1.59e-04	198	176	8	3749_DN
Drug	estradiol, USP; Down 200; 0.01uM; HL60; HG-U133A	HDAC5 TRIO INSR BRAF SVIL ANAPC2 SCNN1A PLXNA1	1.59e-04	198	176	8	387_DN
Drug	Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A	CLASP1 ING1 FRAT1 MPDZ SBF1 SVIL ANAPC2 HNRNPA0	1.59e-04	198	176	8	2062_DN
Drug	Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; HL60; HT_HG-U133A	DGCR2 HDAC5 TUT1 SBNO2 FRY CELSR2 SVIL ANAPC2	1.59e-04	198	176	8	2398_DN
Drug	Lactobionic acid [96-82-2]; Down 200; 11.2uM; HL60; HT_HG-U133A	RAD51D PFKFB3 TRIM23 RNF6 INF2 PLEKHG3 TPP1 ARHGEF3	1.59e-04	198	176	8	1309_DN
Drug	vinblastine sulfate; Up 200; 0.1uM; MCF7; HT_HG-U133A	RAD51D DGCR2 ZBTB17 NLRX1 INSR TEP1 SBF1 ABCB8	1.59e-04	198	176	8	7517_UP
Drug	(-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; HL60; HG-U133A	HDAC5 IRF2BP1 ING1 CELSR2 YLPM1 DHTKD1 PLXNA1 DYRK2	1.64e-04	199	176	8	1780_UP
Drug	Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A	NCLN SBF1 MTOR CNGB3 KAZN PLXNA1 DYRK2 FBXW7	1.64e-04	199	176	8	7203_DN
Drug	Rifampicin [13292-46-1]; Down 200; 4.8uM; PC3; HT_HG-U133A	DGCR2 PRSS8 TRIO PEX6 TUT1 DNAH7 NPM3 CNGB3	1.64e-04	199	176	8	4008_DN
Drug	Isoconazole [27523-40-6]; Up 200; 9.6uM; PC3; HT_HG-U133A	HDAC5 ING1 BTN3A2 SBF1 ABCB8 SAFB2 DMBT1 FBXW7	1.64e-04	199	176	8	5857_UP
Drug	estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A	HDAC5 ING1 TUT1 MAST4 C7orf25 TPP1 YLPM1 FBXW7	1.64e-04	199	176	8	5601_DN
Drug	Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; HL60; HT_HG-U133A	CABP2 PRSS8 MPDZ TUT1 SBNO2 CELSR2 TJP1 CNTN1	1.64e-04	199	176	8	3089_UP
Drug	AH6809; Down 200; 1uM; PC3; HT_HG-U133A	PEX6 MPDZ TEP1 ADCY1 TRIM23 SBNO2 INF2 KAZN	1.64e-04	199	176	8	7075_DN
Drug	Carbachol [51-83-2]; Down 200; 21.8uM; MCF7; HT_HG-U133A	DGCR2 HDAC5 IRF2BP1 NPM3 ZIC3 KRT24 ABCB8 TSC22D4	1.70e-04	200	176	8	3380_DN
Drug	Isoxicam [34552-84-6]; Down 200; 12uM; PC3; HT_HG-U133A	DGCR2 HDAC5 PEX6 MPDZ TRIM23 INF2 SVIL CNGB3	1.70e-04	200	176	8	7268_DN
Drug	Polylysine	PNLIP INSR	1.77e-04	3	176	2	ctd:D011107
Drug	Fmoc-yrosine	INSR CLSTN2	1.77e-04	3	176	2	CID005204799
Drug	trimethyloxonium	ABCB8 ST8SIA2 SCNN1A	1.93e-04	15	176	3	CID000093245
Disease	Ciliopathies	CFTR CDH23 ADGRV1 NPHP4 ZIC3 SCNN1A	4.52e-05	110	171	6	C4277690
Disease	Idiopathic bronchiectasis	CFTR SCNN1A	1.99e-04	4	171	2	cv:C0339985
Disease	Bronchiectasis	CFTR SCNN1A	1.99e-04	4	171	2	cv:C0006267
Disease	Idiopathic bronchiectasis	CFTR SCNN1A	1.99e-04	4	171	2	C0339985
Disease	Acute Erythroblastic Leukemia	CAD DHODH	1.99e-04	4	171	2	C0023440
Disease	hematocrit	SLAIN2 SPI1 DHX38 INSR AFF3 HECTD4 DNAH2 AAK1 PEX6 PFAS ADGRV1 ABCC6 MPRIP ARHGEF3 DMBT1 BSN	2.79e-04	1011	171	16	EFO_0004348
Disease	Intellectual Disability	FRMPD4 TRIO AFF3 PEX6 FRY MTOR TPP1 RHOBTB2 SLC4A10 MACF1	2.97e-04	447	171	10	C3714756
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	IRF2BP1 DHX38 BTN3A2 TENM4 CELSR2 MACF1 PCCB ABCG8	3.12e-04	291	171	8	EFO_0008317, EFO_0020946
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	IRF2BP1 INSR BTN3A2 CELSR2 MACF1 PCCB ABCG8	3.28e-04	222	171	7	EFO_0008317, EFO_0020943
Disease	Chronic obstructive pulmonary disease	CFTR SCNN1A	4.93e-04	6	171	2	cv:C0024117
Disease	N-acetyl-D-glucosamine kinase measurement	NAGK ARHGEF3	4.93e-04	6	171	2	EFO_0008239
Disease	contactin-1 measurement	MUC19 CNTN1	4.93e-04	6	171	2	EFO_0020286
Disease	lung small cell carcinoma (is_implicated_in)	ATRX KMT2D MTOR	5.63e-04	28	171	3	DOID:5409 (is_implicated_in)
Disease	bipolar disorder	SLAIN2 HDAC5 CLASP1 ZCCHC2 BTN3A2 CDAN1 KMT2D TENM4 BRAF SLC4A10 CNTN1	5.76e-04	577	171	11	MONDO_0004985
Disease	Nephronophthisis, familial juvenile	ANKS6 NPHP4	6.88e-04	7	171	2	C1855681
Disease	Esophageal carcinoma	RNF6 CRNN	6.88e-04	7	171	2	C0152018
Disease	Ischemic stroke, von Willebrand factor measurement	DDX31 HECTD4 FGA	6.92e-04	30	171	3	EFO_0004629, HP_0002140
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	BTN3A2 CELSR2 MACF1 PCCB ABCG8	7.13e-04	121	171	5	EFO_0008595, EFO_0020943
Disease	basal cell carcinoma	SPIRE2 ADGRV1 CCDC88B SBNO2 RHOBTB2 TNS3	8.46e-04	189	171	6	EFO_0004193
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	BTN3A2 CELSR2 MACF1 PCCB ABCG8	8.87e-04	127	171	5	EFO_0008595, EFO_0020947
Disease	Hereditary spherocytosis	CAD DHODH	9.14e-04	8	171	2	C0037889
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	IRF2BP1 HECTD4 BTN3A2 CELSR2 MACF1 PCCB ABCG8	9.15e-04	264	171	7	EFO_0008317, EFO_0020944
Disease	low density lipoprotein cholesterol measurement, C-reactive protein measurement	HECTD4 CELSR2 ABCG8	1.09e-03	35	171	3	EFO_0004458, EFO_0004611
Disease	calcium measurement	NLRX1 DNAH2 AAK1 ZCCHC2 ABCC6 CELSR2 MACF1 ABCC12 ARHGEF3 DMBT1 PCCB	1.14e-03	628	171	11	EFO_0004838
Disease	cystic fibrosis (implicated_via_orthology)	CFTR ABCC12	1.17e-03	9	171	2	DOID:1485 (implicated_via_orthology)
Disease	2-hydroxystearate measurement	MUC19 CNTN1	1.17e-03	9	171	2	EFO_0021059
Disease	Pulmonary Cystic Fibrosis	CFTR SCNN1A	1.17e-03	9	171	2	C0392164
Disease	Fibrocystic Disease of Pancreas	CFTR SCNN1A	1.17e-03	9	171	2	C1527396
Disease	apolipoprotein A 1 measurement	HDAC5 SPI1 IRF2BP1 DHX38 AFF3 PEX6 ZBTB42 CD163 CELSR2 DHODH YLPM1 MACF1 ATF1	1.39e-03	848	171	13	EFO_0004614
Disease	sudden cardiac arrest	FMO4 CLSTN2 PARP4 ATF1	1.40e-03	83	171	4	EFO_0004278
Disease	Anemia, Sickle Cell	CAD DHODH	1.46e-03	10	171	2	C0002895
Disease	thyroid gland papillary carcinoma (is_implicated_in)	KMT2D BRAF	1.46e-03	10	171	2	DOID:3969 (is_implicated_in)
Disease	thioredoxin domain-containing protein 12 measurement	SCAP ARHGEF3 BSN	1.50e-03	39	171	3	EFO_0008298
Disease	Glioma	ATRX BRAF DMBT1 FBXW7	1.67e-03	87	171	4	C0017638
Disease	serum alanine aminotransferase measurement	FRAT1 INSR HECTD4 DNAH2 PEX6 MPRIP TENM4 CELSR2 RHOBTB2 DHODH ATF1 PCCB ABCG8	1.73e-03	869	171	13	EFO_0004735
Disease	gastric adenocarcinoma (is_implicated_in)	KMT2D UBR5	1.77e-03	11	171	2	DOID:3717 (is_implicated_in)
Disease	invasive ductal carcinoma (is_implicated_in)	UBR5 DLG1	1.77e-03	11	171	2	DOID:3008 (is_implicated_in)
Disease	Neuroendocrine Tumors	ATRX BRAF	1.77e-03	11	171	2	C0206754
Disease	Cystic Fibrosis	CFTR SCNN1A	1.77e-03	11	171	2	C0010674
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	BTN3A2 CELSR2 MACF1 PCCB ABCG8	1.86e-03	150	171	5	EFO_0004611, EFO_0020947
Disease	Charcot-Marie-Tooth disease	PRX SBF1 INF2	1.86e-03	42	171	3	cv:C0007959
Disease	sleep duration, low density lipoprotein cholesterol measurement	DHX38 CELSR2 DHODH ABCG8	1.97e-03	91	171	4	EFO_0004611, EFO_0005271
Disease	spleen volume	HECTD4 TJP1 ATF1	1.99e-03	43	171	3	EFO_0600047
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	IRF2BP1 DHX38 BTN3A2 CELSR2 MACF1 ABCG8	2.06e-03	225	171	6	EFO_0008317, EFO_0020947
Disease	Cooley's anemia	CAD DHODH	2.12e-03	12	171	2	C0002875
Disease	Thalassemia Intermedia	CAD DHODH	2.12e-03	12	171	2	C0271979
Disease	complement C1q tumor necrosis factor-related protein 1 measurement	CDH23 CELSR2	2.12e-03	12	171	2	EFO_0801493
Disease	granulins measurement	CDH23 CELSR2	2.12e-03	12	171	2	EFO_0008141
Disease	Thalassemia Minor	CAD DHODH	2.12e-03	12	171	2	C0085578
Disease	anxiety disorder, stress-related disorder	CNGB3 GIGYF2	2.12e-03	12	171	2	EFO_0006788, EFO_0010098
Disease	beta Thalassemia	CAD DHODH	2.12e-03	12	171	2	C0005283
Disease	total lipids in very small VLDL measurement	CELSR2 PCCB ABCG8	2.27e-03	45	171	3	EFO_0022156
Disease	Squamous cell carcinoma of esophagus	FAT3 KMT2D RNF6 FBXW7	2.30e-03	95	171	4	C0279626
Disease	selective IgA deficiency disease	CDH23 PFKFB3 MAST4	2.42e-03	46	171	3	EFO_1001929
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	CDH23 ADCY1	2.50e-03	13	171	2	C1846647
Disease	Charcot-Marie-Tooth disease type 4	PRX SBF1	2.50e-03	13	171	2	cv:C4082197
Disease	Nephronophthisis	ANKS6 NPHP4	2.50e-03	13	171	2	C0687120
Disease	free cholesterol in very small VLDL measurement	CELSR2 PCCB ABCG8	2.57e-03	47	171	3	EFO_0022275
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	SMC6 CELSR2 PCCB ABCG8	2.67e-03	99	171	4	EFO_0004611, EFO_0007878
Disease	total lipids in lipoprotein particles measurement	DHX38 CELSR2 ABCG8	2.73e-03	48	171	3	EFO_0022309
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	DHX38 INSR BTN3A2 CELSR2 MACF1 ABCG8	2.78e-03	239	171	6	EFO_0008317, EFO_0020945
Disease	cholestasis (biomarker_via_orthology)	CFTR TJP1 ABCG8	2.90e-03	49	171	3	DOID:13580 (biomarker_via_orthology)
Disease	hepatocellular carcinoma (implicated_via_orthology)	CAD INSR MCM7	2.90e-03	49	171	3	DOID:684 (implicated_via_orthology)
Disease	ocular hypertension, response to triamcinolone acetonide	TTLL3 CDH23 IL17RC	2.90e-03	49	171	3	EFO_0006954, EFO_1001069
Disease	Hereditary Breast and Ovarian Cancer Syndrome	RAD51D MRE11	2.90e-03	14	171	2	C0677776
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	SMC6 CELSR2 PCCB ABCG8	2.98e-03	102	171	4	EFO_0004329, EFO_0004611
Disease	triglycerides to total lipids in medium LDL percentage	CELSR2 PCCB ABCG8	3.07e-03	50	171	3	EFO_0022334
Disease	triglycerides to total lipids in large LDL percentage	CELSR2 PCCB ABCG8	3.25e-03	51	171	3	EFO_0022331
Disease	disease recurrence, colon carcinoma	ANAPC2 CNTN3 MACF1	3.25e-03	51	171	3	EFO_0004952, EFO_1001950
Disease	phospholipids in very small VLDL measurement	CELSR2 PCCB ABCG8	3.25e-03	51	171	3	EFO_0022300
Disease	Ischemic stroke, tissue plasminogen activator measurement	HECTD4 FGA	3.34e-03	15	171	2	EFO_0004791, HP_0002140
Disease	Hemoglobin F Disease	CAD DHODH	3.34e-03	15	171	2	C0019025
Disease	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	SPI1 MTOR FBXW7	3.62e-03	53	171	3	C1961099
Disease	total phospholipids in lipoprotein particles measurement	SPI1 CELSR2 ABCG8	3.62e-03	53	171	3	EFO_0022315
Disease	hepatocellular carcinoma (biomarker_via_orthology)	CAD INSR PFAS MCM7	3.66e-03	108	171	4	DOID:684 (biomarker_via_orthology)
Disease	fibrinogen measurement	DHODH FGA MRPS9 PCCB	3.78e-03	109	171	4	EFO_0004623
Disease	Ischemic stroke, plasminogen activator inhibitor 1 measurement	HECTD4 FGA	3.80e-03	16	171	2	EFO_0004792, HP_0002140
Disease	pancreatitis	HECTD4 ABCG8	3.80e-03	16	171	2	EFO_0000278
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	UBR5 MTOR	3.80e-03	16	171	2	C0334634
Disease	Antithrombotic agent use measurement	HECTD4 CELSR2 ABCG8	4.02e-03	55	171	3	EFO_0009925
Disease	cognitive function measurement	FRMPD4 CLASP1 AFF3 ABCC5 CLSTN2 ZCCHC2 ADGRA2 BTN3A2 NPM3 KMT2D TENM4 MAST4 CNGB3 SLC4A10 GIGYF2 MUC2 PCCB	4.16e-03	1434	171	17	EFO_0008354
Disease	cholesterol to total lipids in large LDL percentage	BTN3A2 CELSR2 ABCG8	4.23e-03	56	171	3	EFO_0022235
Disease	Benign neoplasm of stomach	BRAF UBR5	4.29e-03	17	171	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	BRAF UBR5	4.29e-03	17	171	2	C0496905
Disease	pre-malignant neoplasm (biomarker_via_orthology)	INSR MUC2	4.29e-03	17	171	2	DOID:0060071 (biomarker_via_orthology)
Disease	Carcinoma in situ of stomach	BRAF UBR5	4.29e-03	17	171	2	C0154060
Disease	IGF-1 measurement, IGFBP-3 measurement	ADCY1 CELSR2	4.29e-03	17	171	2	EFO_0004626, EFO_0004627
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	TJP1 MUC2	4.29e-03	17	171	2	DOID:8677 (biomarker_via_orthology)
Disease	factor XI measurement, Ischemic stroke	HECTD4 FGA	4.29e-03	17	171	2	EFO_0004694, HP_0002140
Disease	cognitive function measurement, self reported educational attainment	SPI1 AFF3 CLSTN2 BTN3A2 SLC4A10 BSN PCCB	4.80e-03	355	171	7	EFO_0004784, EFO_0008354
Disease	squamous cell carcinoma (is_implicated_in)	ING1 RNF6	4.81e-03	18	171	2	DOID:1749 (is_implicated_in)
Disease	cancer (implicated_via_orthology)	ING1 PPCS BRAF MTOR DLG1 MACF1	4.85e-03	268	171	6	DOID:162 (implicated_via_orthology)
Disease	triglycerides to total lipids in small LDL percentage	BTN3A2 CELSR2 PCCB	4.90e-03	59	171	3	EFO_0022337
Disease	phospholipids in VLDL measurement	CELSR2 PCCB ABCG8	4.90e-03	59	171	3	EFO_0022301
Disease	von Willebrand factor measurement, coronary artery disease	DDX31 HECTD4 CELSR2 ABCG8	5.01e-03	118	171	4	EFO_0001645, EFO_0004629
Disease	diet measurement, colorectal cancer	ST8SIA2 TNS3	5.35e-03	19	171	2	EFO_0008111, MONDO_0005575
Disease	hippocampal tail volume	MAST4 SLC4A10	5.35e-03	19	171	2	EFO_0009398
Disease	polycystic kidney disease (biomarker_via_orthology)	MTOR ATF1	5.35e-03	19	171	2	DOID:0080322 (biomarker_via_orthology)
Disease	free cholesterol in VLDL measurement	CELSR2 PCCB ABCG8	5.38e-03	61	171	3	EFO_0022276

Protein segments in the cluster

Peptide	Gene	Start	Entry
REQSGAGLRSLGADE	URAD	86	A6NGE7
GSLRTLLGDGVGRQQ	AFF3	166	P51826
ESELNIRGRIGGDSG	PFKFB1	261	P16118
DLIRDQGFRGDGGST	BRAF	381	P15056
DGEVRLGGSLRGAFS	ARHGEF3	391	Q9NR81
RQIVAGLTGDSDGTG	ANAPC2	436	Q9UJX6
LGEGGITLSGGQRAR	CFTR	541	P13569
GGLAGSVRRIQSGLG	CAVIN3	51	Q969G5
LRLGADGAGSTESLG	CCDC88B	1336	A6NC98
DGGITGGLRQEAIDR	CHD5	1071	Q8TDI0
DSRREQGGSGLGSGS	AAK1	6	Q2M2I8
VSLDGQELGTRSGGR	SH3BP5L	361	Q7L8J4
QELGTRSGGRRGSDG	SH3BP5L	366	Q7L8J4
ERIGISGDSAGGNLA	AADAC	181	P22760
GNSRASLEAGEELRG	ADGRA2	961	Q96PE1
ISSLGRTLRGAVAGG	C20orf204	101	A0A1B0GTL2
TLERGNSGLGFSIAG	DLG1	226	Q12959
GHLTRLTGGGGTEEI	GTPBP3	466	Q969Y2
ASGGGTIGLDRIANI	ADGRV1	2326	Q8WXG9
TSLTEKGRAGEGLGR	AJM1	511	C9J069
RASLLDVITGRGHGG	ABCG8	111	Q9H221
NSGGGLSEELGSARR	EHMT2	231	Q96KQ7
LRENGDALSREGSLG	CELSR2	2811	Q9HCU4
GTGRRQDSSVVGDSG	FLG	1696	P20930
GFNVRLSGQDVGRGT	DHTKD1	586	Q96HY7
SGGGGDSRQRRLLAA	CLSTN2	21	Q9H4D0
RDGGGEETTGRVRIN	CDH23	536	Q9H251
RGGRGLEEGVSGESL	CDAN1	131	Q8IWY9
SGAGGTSLEGERGKR	ANO8	6	Q9HCE9
LGLSLSGGDQEDAGR	NAGK	71	Q9UJ70
ILLDTIEGAGASGGR	RAD51D	276	O75771
EVFAGSGTSGQRLGR	PCOLCE	96	Q15113
IASVEGRLTGLGGED	NCLN	201	Q969V3
DRLLGLGSASGSVGR	MMTAG2	116	Q9BU76
LRTLLTGDGGGEATG	MPRIP	876	Q6WCQ1
TATNRRLAELSGGGG	KAZN	31	Q674X7
GLLSSGEVRFRGLTG	LEXM	146	Q3ZCV2
QEAASGELRGGTERG	MEPCE	36	Q7L2J0
FLSQESRTRAGGVGG	NPM3	11	O75607
GEAGRRTNGTIGRIT	PNLIP	176	P16233
TSRLVVGEGEGSQGA	DIO3	6	P55073
EATDGSGTLQGGLRR	BSN	916	Q9UPA5
EGLGTSETAERLGRG	BNIPL	151	Q7Z465
ESRLGGARDELGGRS	CPSF1	711	Q10570
RQGGTRLTITGENLG	PLXNA1	876	Q9UIW2
GRGGSGIRSSRLEED	NXF1	41	Q9UBU9
GRETRGSGSAGGETI	MUC19	226	Q7Z5P9
SLAGGSELQTEGRTR	MUC2	16	Q02817
QRGTASGGEHEGSLR	KATNAL2	361	Q8IYT4
VRRLQGVLGGTGDSL	PEX6	191	Q13608
RGAGLLESELRDGSG	PDE8A	46	O60658
LQGRIGGDSGLSSRG	PFKFB3	261	Q16875
GLGNTGGDIAVELSR	FMO4	191	P31512
VGLGGSGRQSLTRLA	DNAH12	2256	Q6ZR08
GGDSVGGELNRRTVE	KBTBD2	386	Q8IY47
RRLLDGEGGGSSFAE	KRT24	446	Q2M2I5
ESSAAGGQGNSRRGL	MACF1	3476	O94854
QREEAGGRDGGSSLG	INSR	1336	P06213
GGLGVAGGNSTRERL	MED4	16	Q9NPJ6
SSEGRQVLRDLGGAA	NLRX1	876	Q86UT6
QVLRDLGGAAEGGAR	NLRX1	881	Q86UT6
DGTRLQGDIFSVGSG	PSMB11	166	A5LHX3
DRGVQRTDVGNLGSG	PARP4	461	Q9UKK3
AIERLEGSSGGIGER	PAXBP1	426	Q9Y5B6
LEGRDALVRSQTGSG	DDX31	266	Q9H8H2
IGSEVQVLGRGISGS	HECTD4	1746	Q9Y4D8
SSLQELRRALGEGAG	OLIG1	166	Q8TAK6
TGSDGIEGGLLASIR	BPNT2	326	Q9NX62
QELGEGQRSGTEVGR	CRNN	111	Q9UBG3
LRKTARGRGDTDGGS	INF2	986	Q27J81
GRGSSGVGLTAAVLR	MCM7	406	P33993
EAGGDLGRRGTSVLA	NPHP4	926	O75161
GGSQRTISLGAGDRQ	SBF1	181	O95248
GRSSGLGTDVGSRLA	SBF1	1286	O95248
SGGARIQEGVESLAG	PCCB	161	P05166
GAQGRRVVLVTSGGT	PPCS	31	Q9HAB8
TEIGERGANLSGGQR	ABCC5	676	O15440
GRTDGNGSQIRSLGL	ADCY1	1056	Q08828
RSRGGGEGNVDETGN	ATRX	1961	P46100
VNSAAVLRLTGRGGG	GIGYF2	96	Q6Y7W6
AESLSRSRKGGIEGG	C7orf25	21	Q9BPX7
GSGLGQGDRFLTDVT	FRMPD4	1141	Q14CM0
GEVIGGQGSRVERTL	CPNE9	111	Q8IYJ1
SDVGGGGGRNRELTI	CNTN1	711	Q12860
GVGGSGRQSVTRLAA	DNAH7	2341	Q8WXX0
GEIQYSIRDGSGLGR	FAT3	1076	Q8TDW7
FIRNLVTLESGGSGG	FBXW7	656	Q969H0
VSRHGGELLNRSGGS	ANKS6	646	Q68DC2
KGGSRGEEVGELSRG	CNP	356	P09543
RGGSGEGVSCIIRNS	BTN3A2	211	P78410
GDGGSEGALLRRLEQ	DGCR2	481	P98153
DLGTLSGIGTLDGFR	FGA	496	P02671
SEDGRQLRRGSLGGA	MAST4	156	O15021
GASGRAQLRTGDGVL	FRAT1	261	Q92837
TRRGGAQVLGSGATL	KIRREL2	346	Q6UWL6
RAEAGLSGLRGGAAE	KIRREL2	376	Q6UWL6
LGEGGAQASLGRRDL	KIRREL2	491	Q6UWL6
VTVLSGRRGTELGGA	EMILIN1	376	Q9Y6C2
RLDTVAGGLQGLREG	EMILIN1	736	Q9Y6C2
LEGLETLNGTEGGAR	EMILIN3	436	Q9NT22
REGDVTASHGLRGNG	FRY	1391	Q5TBA9
AGLGRSLREAQAGET	HDAC5	1066	Q9UQL6
SDGSDLELRLRGGGS	CD163	366	Q86VB7
SDSGLALRLVNGDGR	DMBT1	96	Q9UGM3
VGIGGSGRQSLARLA	DNAH2	2761	Q9P225
GRGGRGAQEVASTLA	SCNN1A	596	P37088
GRQRRDSGVGSGLEA	SCAP	816	Q12770
SDGSVVLNGGRSRRG	DYRK2	471	Q92630
TNGDGRISVGELRAA	CABP2	166	Q9NPB3
EVNGGGGSRSELVIT	CNTN3	706	Q9P232
TLGSRLANGLGREEA	IRF2BP1	131	Q8IU81
LSGLSGADGRREERG	IL17RC	71	Q8NAC3
SVRSEGGNIRGSFRG	LARP1B	136	Q659C4
GERGTTLSGGQKQRL	ABCB8	606	Q9NUT2
ASLIGVEGGNATRIG	MTOR	91	P42345
SIDGGGTRGVVALQT	PNPLA8	446	Q9NP80
LRSRSGAVQGAGSLG	SLAIN2	31	Q9P270
TTAGTILDGVNVGRG	SVIL	1721	O95425
SGGAGGRSLDSRLEL	TSC22D4	116	Q9Y3Q8
GIRGQELGALRTSGL	ABCC6	516	O95255
LSTKRGRGGGEAAQS	PLEKHG3	1101	A1L390
FSGRSGVEGGRVDLN	ING1	41	Q9UK53
SGELGTRSGETGRKL	ODAD4	586	Q96NG3
GLQGALRSETGGLSG	DHODH	291	Q02127
GLRASTSDGILRGNG	RHOBTB2	361	Q9BYZ6
EGDRGVITDRGGGSQ	SLTM	931	Q9NWH9
RGAVEGAVSGSRQGS	RUFY4	351	Q6ZNE9
EGSFSTLGRLRNGIG	RNF6	226	Q9Y252
VLSQGSGRALRAEGD	SIX6	196	O95475
EIGNSGGRGTIRSAV	ST8SIA2	31	Q92186
GLLSVGIGGRESRNG	SBNO2	941	Q9Y2G9
LAEGLRGTESAGAQG	PPP1R26	901	Q5T8A7
QFSGEVLGRGGLAER	SPI1	251	P17947
LGLLRSGTGAEGAEA	PRSS8	21	Q16651
GTSSRVAVQRGVGSG	TNS3	636	Q68CZ2
SRGGSQRGRADTGLE	MRE11	586	P49959
GDLTEIGERGLNLSG	ABCC12	591	Q96J65
LTRGEGGFGLTLRGD	RHPN1	516	Q8TCX5
GSGTRVGLLNANREG	PIGW	291	Q7Z7B1
GLGTSSGRTELRVGS	ANHX	291	E9PGG2
DLEGLRGSQNEGAGR	APOBR	66	Q0VD83
GRGSQVEAFESREGG	APOBR	821	Q0VD83
TRGRKGDGENSGVSA	ATF1	76	P18846
GEISLLAAGGGNRRT	CNGB3	591	Q9NQW8
TEGRGGSEVEGGRTA	CLASP1	1226	Q7Z460
AGGRVSLEGGTLRAA	CNNM1	51	Q9NRU3
GDSSGGERLGARRNS	C11orf96	226	Q7Z7L8
RVGGGLGSRAQEELL	ZCCHC2	246	Q9C0B9
RQRSSGLSEAASGGG	ZIC3	121	O60481
VLIARGGRGAGSQSL	nan	136	Q6ZSN1
TDGGSLATGGRDRSL	TEP1	2071	Q99973
GGLGFSVVGLRSENR	MPDZ	146	O75970
GSGAGLRVNTSEGVV	SPEN	2801	Q96T58
TVSGGGRSAQAGAIR	MRPS9	331	P82933
ARRKEGGSETGVGEG	SLC26A1	571	Q9H2B4
IGGLNVQTSESGLRG	HNRNPA0	11	Q13151
EQATKRTRSEGGGTG	TUT1	636	Q9H6E5
DTGDLLLRGDGSVGA	SPIRE2	61	Q8WWL2
GGDAGLGTSQRRRKS	SPATA31D1	1306	Q6ZQQ2
ARSGSGDQEEGGLRV	PRX	1421	Q9BXM0
SGATTGTGGRIRDVQ	PFAS	321	O15067
TFGGLLGEATEGRIS	SLC4A10	526	Q6U841
ILGLSGGRRTLENGV	TENM4	2631	Q6N022
VGLGGRAVATNRGSS	SMC6	91	Q96SB8
EDINLIRGTGSGGQL	SRPRA	276	P08240
GALDNTGGLTSTGRL	DHX38	931	Q92620
GLEGGGVASQDRGSR	SAFB2	921	Q14151
GSINGATRLTIRGEG	PKHD1L1	41	Q86WI1
LGLDSIAVGGSRVDG	TTLL3	746	Q9Y4R7
GGLGSGFASNREELS	CAD	561	P27708
GLQGSQDRGAAGSRE	YLPM1	1096	P49750
LSGEGSRELELGAGR	ZBTB42	266	B2RXF5
DSVGLRLAGGNDVGI	TJP1	431	Q07157
SEGAEGLGGTDLRGR	VWA5B2	1151	Q8N398
SGQELGSEARGLRSG	ZBTB17	276	Q13105
GSRSLVEQLLSGEGG	TTC30A	131	Q86WT1
RLLDGVRSGQSSGRG	SH3RF2	71	Q8TEC5
RLSSESEGAGGGLLE	ZNF831	201	Q5JPB2
AGVDSGRQGSRGTAV	TRIM23	11	P36406
RGAGRLQNSGTGLST	ZFAND4	586	Q86XD8
TGGGKRAESQTRGTE	USP2	86	O75604
DGQRLLTGSEDGTAR	WDR86	26	Q86TI4
TLGLELRGVRAGDSG	SIGLEC11	316	Q96RL6
NSGRLRGTVVGGRQD	UFL1	226	O94874
EERGRNEGLSSGTLS	TRIO	1831	O75962
GSETLGRLAGNTLGS	UBR5	116	O95071
IRTGRDRGSGLLGSQ	UBR5	161	O95071
VGQQGRGRAGIEASL	TPP1	261	O14773
TGRGSEGLRAEINGH	KMT2D	4476	O14686